Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine conjugates the O-polysaccharide of Shigella flexneri 2a to Pseudomonas aeruginosa exotoxin A. We describe a Phase 2b proof-of-concept c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	EBioMedicine Jg. 66; S. 103310
Hauptverfasser:	Talaat, Kawsar R., Alaimo, Cristina, Martin, Patricia, Bourgeois, A. Louis, Dreyer, Anita M., Kaminski, Robert W., Porter, Chad K., Chakraborty, Subhra, Clarkson, Kristen A., Brubaker, Jessica, Elwood, Daniel, Frölich, Rahel, DeNearing, Barbara, Weerts, Hailey, Feijoo, Brittany L., Halpern, Jane, Sack, David, Riddle, Mark S., Fonck, Veronica Gambillara
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands Elsevier B.V 01.04.2021 Elsevier
Schlagworte:	Advanced Basic Science Bioconjugate vaccine Controlled human challenge study Internal Medicine Research Paper Shigella Shigella flexneri 2a Vaccine Controlled human challenge study Vaccine Shigella flexneri 2a Bioconjugate vaccine Shigella
ISSN:	2352-3964, 2352-3964
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!